Clinical and laboratory study of the antiperinuclear factor in rheumatoid arthritis;Estudo clinico-laboratorial do fator antiperinuclear na artrite reumatoide

Revista Brasileira de Reumatologia

Volumn 40, Issue 4, 2000, Pages 159-167

  Da Silveira, I G ^a   Keiserman, M W ^a   Von Muhlen, C A ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antiperinuclear factor; Autoantibody; Laboratorial diagnosis; Profilaggrin antibody; Rheumatoid arthritis

Indexed keywords

ANTIPERINUCLEAR FACTOR; RHEUMATOID FACTOR;

ADULT; AGE; AGED; ARTHROPATHY; ARTICLE; BONE EROSION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ASSAY; REMISSION; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; SEROPREVALENCE; SEX DIFFERENCE; SJOEGREN SYNDROME; SUBCUTANEOUS NODULE;

EID: 0033804995     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis
2. Autoimmunity in rheumatoid arthritis
3. Specificity, pathogenicity, and clinical value of antiendothelial cell antibodies
4. Antibodies to cytokeratins in inflammatory arthropathies
5. A new serum factor in patients with rheumatoid arthritis: The antiperinuclear factor
6. Perinuclear factor (profilaggrin) autoantibodies
7. Oral mucous membrane
8. Filaggrin
9. Profilaggrin, a high-molecular-weight precursor of filaggrin in human epidermis and cultured keratinocytes
10. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: Comparison with rheumatoid factor
11. Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled
12. Valor diagnostico do fator antiperinuclear e do anticorpo antiestrato corneo na artrite reumatoide. Parte I
13. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process
14. The antiperinuclear factor I: Clinical and serologic associations
15. Clinical heterogeneity of rheumatoid arthritis and antiperinuclear factor
16. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
17. European Community Study Group on Diagnostic Criteria for Sjogren's Syndrome. Preliminary criteria for the classification of Sjogren's syndrome
18. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis
19. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles
20. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis
21. Antiperinuclear factor: A marker autoantibody for rheumatoid arthritis: Colocalisation of the perinuclear factor and profilaggrin
22. Histologic and electron microscopic characterization of the antiperinuclear factor antigen
23. Demonstration of an antiperinuclear factor in patients with rheumatic diseases, liver diseases and lung tuberculosis using fluorescence technic
24. Prospect for additional laboratory criterion for rheumatoid arthritis
25. Factor antiperinuclear: Aspectos tecnicos, estudios acerca del antigeno y utilitad clinica en la artritis reumatoide
26. Studies on the anti-perinuclear factor
27. Antiperinuclear factor - Clinical, serological and genetic correlates in Israeli patients with rheumatoid arthritis
28. Antiperinuclear factor: Indicator of more severe disease in seronegative rheumatoid arthritis
29. The diagnostic value of antiperinuclear (APF)
30. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Study of 600 patients and meta-analysis of the literature
31. Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis
32. The antiperinuclear factor. I. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis
33. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis
34. Antiperinuclear factor in an Italian series of patients with rheumatoid arthritis
35. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis
36. Clinical expression of rheumatoid arthritis in Chilean patients
37. Articular patterns in the early course of rheumatoid arthritis
38. Secondary Sjogren's syndrome in rheumatoid arthritis
39. The antiperinuclear factor in Sjogren's syndrome in the presence or absence of rheumatoid arthritis
40. Antinuclear antibodies in systemic lupus erythematosus before and after treatment and in chronic progressive polyarthritis. Some observations on the antiperinuclear factor
41. Antiperinuclear factor and disease activity in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy
42. Significado clinico do fator antiperinuclear e anticorpo antiestrato corneo na attrite reumatoide. Parte 2
43. Clinical, laboratory, and radiographic features of rheumatoid arthritis with and without nodules
44. Autoantibodies predicting the outcome of rheumatoid arthritis: Evaluation in two subsets of patients according to severity of radiographic damage
45. Antibody to stratum corneum (antikeratin antibody) and antiperinuclear factor: Markers for progressive rheumatoid arthritis
46. Extra-articular manifestations of rheumatoid arthritis
47. Clinical features - Systemic involvement